日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancer

STAR(基质-肿瘤人工智能风险)评估:人工智能衍生的肿瘤-基质比例与患者生存率的关联性,在卵巢上皮癌中提供了除KELIM之外的额外预后价值

Aggarwal, Arpit; Madill, Morgann; Jana, Mayukhmala; Pathak, Tilak; Starr, Timothy K; Winterhoff, Boris; Tessier, Katelyn M; Erickson, Britt K; Nelson, Andrew C; Lou, Emil; Madabhushi, Anant; Bazzaro, Martina

Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools

利用基于人工智能的工具,通过定量和定性指标预测卵巢癌预后并扩展对肿瘤间质的研究

Madill, Morgann; Aggarwal, Arpit; Madabhushi, Anant; Erickson, Britt K; Nelson, Andrew C; Lou, Emil; Bazzaro, Martina

Proteomic Analysis of ARID1A-Deficient Ovarian Clear Cell Carcinoma Cells Reveals Differential Mitochondria ETC Subunit Abundances and Targetable Mitochondrial Pathways.

ARID1A 缺陷型卵巢透明细胞癌细胞的蛋白质组学分析揭示了线粒体 ETC 亚基丰度的差异和可靶向的线粒体通路

Perez Jesenia M, Ryu Joohyun, Khan Hannah, Shetty Mihir, Parker Emma, D'Arcy Padraig, Zhu Shijia, Bazzaro Martina, Thomas Stefani N

Protocol for purifying biologically active microtubule-severing protein UNC-45A from E.coli using GST-affinity and spin columns.

利用 GST 亲和柱和旋转柱从大肠杆菌中纯化具有生物活性的微管切割蛋白 UNC-45A 的方案

Hoshino Asumi, Krishnan Nimisha, Shetty Mihir, Ross Jennifer L, Bazzaro Martina

Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer

肿瘤间质比例预测卵巢癌患者的化疗耐药性

Lou, Emil; Clemente, Valentino; Grube, Marcel; Svedbom, Axel; Nelson, Andrew C; Blome, Freya; Staebler, Annette; Kommoss, Stefan; Bazzaro, Martina

The Ovary-Brain Connection

卵巢与大脑的联系

Yousif, Abdelrahman; Ebeid, Ahmed; Kacsoh, Balint; Bazzaro, Martina; Chefetz, Ilana

Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction

卵巢癌间质成分的临床意义:预后预测中数量比质量更重要

Lou, Emil; Clemente, Valentino; Grube, Marcel; Svedbom, Axel; Nelson, Andrew; Blome, Freya; Staebler, Annette; Kommoss, Stefan; Bazzaro, Martina

The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.

DNA胞嘧啶脱氨酶APOBEC3B是透明细胞卵巢癌对铂类药物反应性的分子决定因素

Serebrenik Artur A, Argyris Prokopios P, Jarvis Matthew C, Brown William L, Bazzaro Martina, Vogel Rachel I, Erickson Britt K, Lee Sun-Hee, Goergen Krista M, Maurer Matthew J, Heinzen Ethan P, Oberg Ann L, Huang Yajue, Hou Xiaonan, Weroha S John, Kaufmann Scott H, Harris Reuben S

Dienone Compounds: Targets and Pharmacological Responses

二烯酮类化合物:靶点和药理反应

Bazzaro, Martina; Linder, Stig

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

靶向线粒体治疗化疗耐药性卵巢癌

Emmings, Edith; Mullany, Sally; Chang, Zenas; Landen, Charles N Jr; Linder, Stig; Bazzaro, Martina